ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
67.115,56
0,26%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Itália
  5. BIT
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Notícias

AMGN

Amgen (AMGN)

Amgen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:BIT:AMGN
DataHoraFonteTítuloCódigoCompanhia
19/10/200916:57Dow Jones News2nd UPDATE: FDA Delays Decision On Amgen Bone DrugNASDAQ:AMGNAmgen Inc.
19/10/200913:17Dow Jones NewsUPDATE: FDA Delays Decision On Amgen Bone Drug For Added InfoNASDAQ:AMGNAmgen Inc.
19/10/200911:55Dow Jones NewsFDA Seeks Added Info On Amgen Bone Drug, Delays DecisionNASDAQ:AMGNAmgen Inc.
16/10/200915:55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesNASDAQ:AMGNAmgen Inc.
14/10/200915:44Dow Jones NewsAmgen's Bone Drug May Face Delays In FDA DecisionNASDAQ:AMGNAmgen Inc.
12/10/200911:57Dow Jones NewsDrug Stocks Edge Higher; DepoMed SinksNASDAQ:AMGNAmgen Inc.
01/10/200914:22Dow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketNASDAQ:AMGNAmgen Inc.
23/09/200911:22Dow Jones NewsConflicting Erbitux Study Data Hurts Merck SharesNASDAQ:AMGNAmgen Inc.
23/09/200906:59Dow Jones NewsMerck Shares Rise On Positive Erbitux Data For Colon CancerNASDAQ:AMGNAmgen Inc.
22/09/200908:28Dow Jones NewsAmgen's Denosumab Aids Bones In Breast-Cancer PatientsNASDAQ:AMGNAmgen Inc.
17/09/200917:04Dow Jones NewsAmgen Hiring Mobile Reps In Building Bone Drug Sales ForceNASDAQ:AMGNAmgen Inc.
17/09/200910:31Dow Jones NewsMerck KGaA's Erbitux Data May Be Upstaged By Rival VectibixNASDAQ:AMGNAmgen Inc.
15/09/200918:52Dow Jones News2nd UPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
15/09/200918:39Dow Jones NewsUPDATE: US Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
15/09/200913:22Dow Jones NewsUS Court Won't Disturb Injunction Against Roche Anemia DrugNASDAQ:AMGNAmgen Inc.
25/08/200918:46Dow Jones NewsAmgen: Aranesp Doesn't Show Significant Bad Effects In StudyNASDAQ:AMGNAmgen Inc.
17/08/200910:40Dow Jones NewsEuropean Biosimilars Market May Hint At Limited US ThreatNASDAQ:AMGNAmgen Inc.
14/08/200912:29Dow Jones NewsSUBSCRIBERS: FDA OKs Saphris News Already ReportedNASDAQ:AMGNAmgen Inc.
13/08/200920:34Dow Jones News5th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200919:51Dow Jones News4th UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200919:03Dow Jones News3rd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200918:13Dow Jones News2nd UPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200917:10Dow Jones NewsUPDATE:FDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
13/08/200916:38Dow Jones NewsFDA Panel Backs Denosumab As Osteoporosis TreatmentNASDAQ:AMGNAmgen Inc.
11/08/200913:56Dow Jones NewsFDA: Amgen Osteoporosis Drug Could Affect Immune SystemNASDAQ:AMGNAmgen Inc.
07/08/200914:01Dow Jones NewsAmgen's Cancer News Promising, But Bone Drug Still The FocusNASDAQ:AMGNAmgen Inc.
04/08/200916:43Dow Jones NewsUPDATE: FDA: Requires Stronger Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
04/08/200915:05Dow Jones NewsFDA: Requires Stronger Class Warnings For TNF Blocker DrugsNASDAQ:AMGNAmgen Inc.
04/08/200913:13Dow Jones NewsAmgen's Positive Bone Drug Data Missed Some High ExpectationsNASDAQ:AMGNAmgen Inc.
03/08/200919:01Dow Jones NewsAmgen Bone Drug Shows Promise In Phase 3 TrialNASDAQ:AMGNAmgen Inc.
 Apresentando as notícias mais relevantes sobre:BIT:AMGN

Seu Histórico Recente

LSE
0N78
Eyemaxx Real Estate
BOV
PETRV36
PETRV36 Ex:32,12
TSXV
NKW
Oceanic Wind Energy
TG
VX1
Vertex Pharmac Dl 01
LSE
0MRK
Logismos Information Sys...
EU
RECT
Recticel
NYSE
HHC
Howard Hughes
NASDAQ
MGIC
Magic Software Enterprises
LSE
0N99
Ludwig Beck Am Rathausec...
BOV
MTSA3
METISA ON
TSXV
WHR.P
NYSE
AQS
NASDAQ
CTXRW
Citius Pharmaceuticals
NASDAQ
WOLF
Great Wolf Resorts
NYSE
CEM
ClearBridge MLP and Mids...
LSE
0JSG
Euro Ressources
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados